Biotech

All Articles

Arch shuts $3B-plus fund to promote biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Life Sciences, Arch Endeavor Partners ...

Orion to utilize Aitia's 'electronic doubles' to discover new cancer medications

.Finnish biotech Orion has snooped prospective in Aitia's "electronic double" technician to establis...

Windtree's shock med raises blood pressure in latest period 2 succeed

.While Windtree Rehabs has strained to develop the financial roots needed to have to endure, a perio...

2 cancer cells biotechs combine, generating global impact

.OncoC4 is taking AcroImmune-- and its in-house medical production capacities-- under its fly an all...

Amgen files first stage 3 win for $400M dermatitis medication

.Amgen has discussed (PDF) the 1st phase 3 data on its own $400 million dermatitis medicine, linking...

Biogen, UCB record phase 3 lupus gain after stopping working earlier test

.Biogen and also UCB's bank on improving in to stage 3 on the back of a broken research study aims t...

Aptadir really hopes brand new RNA inhibitors may turn around challenging cancers

.Italian biotech Aptadir Rehabs has actually released with the assurance that its pipeline of precli...

Wave surfs DMD success to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD) ...

Sanofi tweezes new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, using...

Achilles trickles tissue therapy course, supports for layoffs after missing out on 'office practicality' goals

.Achilles Therapies has shreded its own strategy. The English biotech is stopping work on its clinic...